Concord Biotech Ltd

Concord Biotech Q2 FY27 Results: Net Profit ₹69.6 Cr, Up 10.3% YoY

Concord Biotech Ltd reported revenue from operations of ₹309.1 Cr (+25.1% YoY) and net profit of ₹69.6 Cr (+10.3% YoY) for Q2 FY27.

Key figure

Net profit ₹69.6 Cr · +10.3% YoY

Concord Biotech Q1 FY27 Results: Net Profit ₹57.7 Cr, Up 30.8% YoY

Concord Biotech Ltd reported revenue from operations of ₹257.5 Cr (+26.2% YoY) and net profit of ₹57.7 Cr (+30.8% YoY) for Q1 FY27.

Key figure

Net profit ₹57.7 Cr · +30.8% YoY

Concord Biotech Q4 FY26 Results: Net Profit ₹88.5 Cr, Down 37.0% YoY

Concord Biotech Ltd reported revenue from operations of ₹326.1 Cr (-24.1% YoY) and net profit of ₹88.5 Cr (-37.0% YoY) for Q4 FY26.

Key figure

Net profit ₹88.5 Cr · -37.0% YoY

Concord Biotech Financial Results

Concord Biotech approved its FY26 audited financial results and recommended a final dividend of Rs. 7.55 per share. It also appointed Mrs. Ekta Gupta as an Additional Independent Director.